Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

FETZIMA DIN 02440997

Status: Marketed
Holder: ABBVIE CORPORATION
Molecule: LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)
Available to quote

Health Canada record

Active ingredient(s)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 80 MG
Dosage formCapsule (Extended-Release)
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCN06AX28 LEVOMILNACIPRAN
Original market date22-Apr-2016
Current status date10-Oct-2023
SourceHealth Canada DPD

Establishment licence of the holder

AbbVie Corporation — licence 101988, currently licensed, last inspection rating C (2023-07-18).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)

DINProductCompanyFormStrengthStatus
02564831APO-LEVOMILNACIPRANAPOTEX INCCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 20 MGApproved
02564858APO-LEVOMILNACIPRANAPOTEX INCCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 40 MGApproved
02564866APO-LEVOMILNACIPRANAPOTEX INCCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 80 MGApproved
02564874APO-LEVOMILNACIPRANAPOTEX INCCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 120 MGApproved
02440989FETZIMAABBVIE CORPORATIONCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 40 MGMarketed
02441004FETZIMAABBVIE CORPORATIONCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 120 MGMarketed
02440970FETZIMAABBVIE CORPORATIONCapsule (Extended-Release)LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE) 20 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
288462022-08-29New Drug Submission (NDS)Administrative: Merger/Buy-out
185662016-10-13New Drug Submission (NDS)MANUFACTURER NAME CHANGE
168882015-05-08New Drug Submission (NDS)
Request a quote for FETZIMA

How to read a Canadian DIN record